Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB Biopharma SRL
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The participant could, in the opinion of the Investigator, benefit from long-term dapirolizumab pegol (DZP) treatment
The participant completed one of the parent studies within 4 weeks prior to entry to this study
You may not be if
\- Study participant has any medical or psychiatric condition (including conditions due to neuropsychiatric systemic lupus erythematosus (SLE)) that, in the opinion of the Investigator, could jeopardize or would compromise the study participant's ability to participate in this study. This includes study participants with a life-threatening condition or ongoing malignancies at the start of the study
